News February 28, 2023: Hallux Reaches Enrollment Target In Onychomycosis Trial September 22, 2022: Hallux Inc Opens Third Clinical Site To Evaluate Novel Onychomycosis Product Candidate July 7, 2022: Hallux Inc Opens Second Clinical Site To Evaluate Novel Onychomycosis Product Candidate May 18, 2022: Seth M. Birnbaum Joins Pharma Company Hallux Inc. Board Of Directors April 6, 2022: Hallux Inc. Announces Closing Of $9.4m Series A-2 Financing January 12, 2022: Hallux Starts Phase 2 Clinical Study Of Novel Subungual Gel For Onychomycosis November 8, 2016: Hallux Announces Start Of Phase 2 Clinical Trial
